A new love dr*g has been approved by the FDA which can apparently boost female libido as one may call it.
The love dr*g is going to be second ever to enter the market of boosting libido for women. The drug which is being touted as “female viagra” has not been as successful as one would expect it to be.
The generic name of the dr*g is Bremelanotide, follows the launch of the pill Addyi. The concept of Addyi is that of a daily pill which is supposed to treat Hypoactive low sexual desire disorder (HSDD) in pre-menopausal women.
The new medicine, Vyleesi is set to launch in September.
The new dr*g will also treat the same disorder but in a different intake method.

What is HSDD?
Low sexual desire in HSDD patients has not yet been connected with anything in particular. The mental health, emotional connectivity in a relationship or even medical issues have not been connected to HSDD yet.
Stephen Snyder, MD, associate clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai and author of Love Worth Making: How to Have Ridiculously Great Sex in a Long-Lasting Relationship, once said that the women suffering this disorder have lost their once healthy libido even though they want their partners.
Vyleesi reportedly activates receptors for the group of hormones which are being called melanocortins.
The love dr*g has to be injected into the thigh or abdomen 45 minutes before you get steamy in bed.
How does it work?
The mechanism by which the medicine works remains unknown to the FDA. The clinical trial results for Vyleesi have been more than disappointing. But that doesn’t e
The Facts – effective or side effective?
Only 25% of patients who used Vyleesi reported an increase in their sexual desire which is closely similar to those who were taking a placebo during the trial which is at 17%.

The side-effects include nausea and blackening of gums. 40% of all patients experienced nausea and 18% patients dropped out of the trial.
8% of all patients stopped because of nausea.
Blackening of gums is another side effect which occurred in 1% of all patients. In half of these patients, the gums have not gone back to normal colour, even after the treatment was stopped. The skin colour was also affected in some of these cases.
This is not a breakthrough
While this dr*g is being marketed as ‘female viagra’, Vyleesi is not a breakthrough love dr*g
- It doesn’t work;
- Has not got enough credibility to be called a breakthrough;
- Will affect lives after it reaches the markets;
- Side effects are not all known at this moment.
Regardless of what the drug Vyleesi would mean for the market, the big picture is that women don’t have any way to chemically arouse themselves without side-effects.
And it often happens so that the emotional aspect of sexual attraction is missed out on. Especially in the case of women, it happens so that we forget that no emotional attraction may be the reason behind no libido.
There is one other love dr*g is available in the medical industry today by the name of Addyi. While Vyleesi is a medicine taken ad hoc, Addyi is a daily dosage medication. Addyi boosts levels of certain hormones in the brain and gradually treat HSDD.
Addyi has been in the market since 2015 but this medicine, too, has its own number of side effects.
Nothing is really helpful for women going through low libido, because it’s
cure is still unavailable in the market.
That being said, low libido is not necessarily caused by a disease. It may just be something that happens because of variation or gap in the time when you have high libido vis a vis, your partner.
